Geneos Wealth Management’s Associated Banc-Corp ASB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-200
| Closed | -$5.15K | – | 2471 |
|
|
2025
Q4 | $5.15K | Hold |
200
| – | – | ﹤0.01% | 2131 |
|
|
2025
Q3 | $5.14K | Sell |
200
-287
| -59% | -$7.36K | ﹤0.01% | 2136 |
|
|
2025
Q2 | $11.9K | Buy |
487
+87
| +22% | +$1.96K | ﹤0.01% | 2251 |
|
|
2025
Q1 | $9.01K | Buy |
400
+200
| +100% | +$4.8K | ﹤0.01% | 2595 |
|
|
2024
Q4 | $4.78K | Hold |
200
| – | – | ﹤0.01% | 2347 |
|
|
2024
Q3 | $4.31K | Buy |
+200
| New | +$4.34K | ﹤0.01% | 2112 |
|
|
2022
Q3 | – | Sell |
-14,440
| Closed | -$267K | – | 2032 |
|
|
2022
Q2 | $267K | Buy |
14,440
+8,440
| +141% | +$171K | 0.01% | 648 |
|
|
2022
Q1 | $136K | Hold |
6,000
| – | – | 0.01% | 961 |
|
|
2021
Q4 | $135K | Hold |
6,000
| – | – | 0.01% | 1056 |
|
|
2021
Q3 | $131K | Hold |
6,000
| – | – | 0.01% | 1050 |
|
|
2021
Q2 | $122K | Sell |
6,000
-5,110
| -46% | -$113K | ﹤0.01% | 1080 |
|
|
2021
Q1 | $243K | Hold |
11,110
| – | – | 0.01% | 888 |
|
|
2020
Q4 | $133K | Buy |
11,110
+8,880
| +398% | +$135K | 0.01% | 1008 |
|
|
2020
Q3 | $27K | Buy |
2,230
+9
| +0.4% | +$119 | ﹤0.01% | 1510 |
|
|
2020
Q2 | $28K | Buy |
2,221
+428
| +24% | +$5.82K | ﹤0.01% | 1463 |
|
|
2020
Q1 | $22K | Buy |
1,793
+9
| +0.5% | +$161 | ﹤0.01% | 1464 |
|
|
2019
Q4 | $39K | Buy |
1,784
+5
| +0.3% | +$106 | ﹤0.01% | 1382 |
|
|
2019
Q3 | $36K | Buy |
1,779
+5
| +0.3% | +$101 | ﹤0.01% | 1331 |
|
|
2019
Q2 | $37K | Buy |
1,774
+5
| +0.3% | +$109 | ﹤0.01% | 1338 |
|
|
2019
Q1 | $37K | Buy |
1,769
+5
| +0.3% | +$110 | ﹤0.01% | 1284 |
|
|
2018
Q4 | $34K | Buy |
1,764
+4
| +0.2% | +$91 | ﹤0.01% | 1269 |
|
|
2018
Q3 | $45K | Buy |
1,760
+4
| +0.2% | +$109 | ﹤0.01% | 1212 |
|
|
2018
Q2 | $47K | Sell |
1,756
-132
| -7% | -$3.54K | ﹤0.01% | 1075 |
|
|
2018
Q1 | $46K | Buy |
1,888
+3
| +0.2% | +$76 | ﹤0.01% | 1024 |
|
|
2017
Q4 | $47K | Buy |
1,885
+595
| +46% | +$14.9K | ﹤0.01% | 1021 |
|
|
2017
Q3 | $31K | Hold |
1,290
| – | – | ﹤0.01% | 1149 |
|
|
2017
Q2 | $32K | Sell |
1,290
-40
| -3% | -$983 | ﹤0.01% | 1095 |
|
|
2017
Q1 | $32K | Sell |
1,330
-20
| -1% | -$502 | ﹤0.01% | 1055 |
|
|
2016
Q4 | $33K | Hold |
1,350
| – | – | ﹤0.01% | 982 |
|
|
2016
Q3 | $26K | Buy |
1,350
+20
| +2% | +$378 | ﹤0.01% | 1030 |
|
|
2016
Q2 | $22K | Hold |
1,330
| – | – | ﹤0.01% | 1081 |
|
|
2016
Q1 | $23K | Buy |
+1,330
| New | +$23.3K | ﹤0.01% | 1038 |
|
Other funds holding ASB
VPM
VCM
NAMI
Geneos Wealth Management's ASB Position: Q1 2026 in Review
Geneos Wealth Management sold out of Associated Banc-Corp (ASB) in Q1 2026, closing a stake of 200 shares — an estimated $5.15K sold.
Geneos Wealth Management first reported a position in ASB in Q1 2016 and held it in 32 quarters. The position peaked at $267K in Q2 2022. 368 funds tracked by Wall St. Rank hold ASB as of Q1 2026.
- Geneos Wealth Management reported no remaining Associated Banc-Corp position as of Q1 2026 after selling out during the quarter.
- Geneos Wealth Management sold 200 Associated Banc-Corp shares in Q1 2026, an estimated $5.15K.
- Geneos Wealth Management first reported a position in Associated Banc-Corp in Q1 2016 and held it in 32 quarters.
- Geneos Wealth Management's Associated Banc-Corp position peaked at $267K in Q2 2022.
- 368 funds tracked by Wall St. Rank held Associated Banc-Corp as of Q1 2026.
Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.